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Object es. This study was undertaken to determine elig1bility
for and benefit of bo lytic therapy in patients with acute
inferior t infarction ith or without right ventricular
involvement.
Fight ventricular Involvement commonly compli-
acute Wedw myocardial Infarction nd Is considered to
have pngaostic relevance. We b that the presence of
right
vat.
, d early by ST segment
elevation In the riot precordial bad (V41t), may be of clinical
Importance In Identifying patients who will benefit most from
bolytic therapy.
Methods. We studied 200 consecutive patients with acute
inferior myocardial Inbretion to assess the p
	
of
t ventricular inbretion in those considered eligible or ineligi-
ble for repe therapy. Prognostic angbses were based a the
period and a 1- to 6-year follow-up (mean [±3D] 37 t
12 months) .
Resa& . ST segment elevation in lead V4R was a reliable
marker of right ventricular infarction (sensitivity %, speci.-
llclty 78%, diagnostic 83%) In 107 patients (54%)
with Inferior myocardial infarction . Seventy-one eligible patients
Thrombolytic therapy is the treatment of choice in patients
with acute myocardial infarction . However, in several
patient groups the risk/benefit ratio of thrombolytic ther-
apy continues to be controversial (1,2). Thus, during acute
inferior myocardial infarction, most studies showed no effect
(3-5) or only a borderline beneficial effect of trombolysis
(6-9), whereas other studies (10,11) and a recent meta-
analysis of these studies provided increasing evidence that
thrombolytic therapy may reduce mortality in an increased
sample size (1). Any benefit provided by the use of throm-
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(36%) received th bolytic therapy and had a lower mortality
(8% (6 of 71]) and complication (31% [22 of 71]) rate than
ineligible patients ( ty rate 25% [32 of 1291, p < 0.001 ;
complication rate 56% [72 of 129], p < 0.01). However, the
overall beacfit of th lysis was restricted to patients with right
ventricular infarction complicating acute inferior myocardial in-
f (with vs. without th ysis, respectively- mortality
rate 10% vs. 42%, p < O. W; ' lion rate 34% vs . 54%,
p < 0.05) . In the absence of right ventricular infarction, no
difference was observed in the mortality (7% vs . 6%, p ® NS) and
major in-hospital co (27% vs. 29%, p = NS) rates,
whether or not the patient underwent thronbolytic therapy .
Posthospital course over 37 ± 12 months was not different in
patients with and without riot ventricular i ion but was best
in all patients considered for reperfusion therapy.
Co>wlaasions
. During acute inferior myocardial infarction, the
right precordial electrocardiogram is a simple but promising
variable to identify a subgroup of patients with an unfavorable
course who will benefit most from thrombolytic therapy .
(J Am Cog Canddiol 1994;24:362-9)
bolysis may be of particular importance in up to half of
patients in whom right ventricular infarction complicates
acute inferior myocardial infarction (12,13). These patients
are known to have the highest risk of in-hospital death or
major complications (e .g., hemodynamic intolerance, severe
atrioventricular [.4V] block and tachyarrhythmic rhythm
disturbances [14-20]), independent of additional left ventric-
ular dysfunction (21,22) . Data addressing the effects of
reperfusion therapy in patients with and without right ven-
tricular infarction are limited .
The Thrombolysis in Myocardial Infarction II trial (TIMI
II) collected evidence that successful thrombolysis reduces
the incidence of right ventricular involvement during inferior
myocardial infarction from 42% to l3%a (23) . In a smaller
study, Schuler et al. (24) studied 19 patients with proximal
occlusion of the right coronary artery who had improvement
of right ventricular function that was closely correlated to
success of reperfusion therapy. By contrast, Verani et al .
0735-109719457.00
(25) showed that improvement of right ventricular function
was similar in patients with and without reopening of the
right coronary artery by thrombolytic therapy . At present it
is uncertain whether the presence or absence of right ven-
tricular involvement during acute inferior myocardial infarc-
tion has any influence on the in-hospital course of patients
considered eligible or ineligible for thrombolytic therapy
(W,26) .
ST segment elevation ?O .l mV in the right precordial
lead
VA
has recently been recognized to be a simple,
reliable and widely available marker of right ventricular
infarction when assessed during acute inferior myocardial
infarction (27-33) . In addition, ST segment elevation in lead
V411 was also found to be of prognostic relevance, identify-
ing a subgroup of patients with acute inferior myocardial
infarction and an increased in-hospital mortality and compli-
cation rate (20,34,35) .
In a prospective study in 200 consecutive patients with
acute inferior myocardial infarction, the prognostic impact
of right ventricular infarction in patients found eligible and
ineligible for reperfusion therapy was evaluated during the
in-hospital and long-term course .
Methods
Patients . In a prospective study from August 1985 to
January 1990 we included 200 consecutive and consenting
patients admitted to the University Hospital of Freiburg with
acute inferior myocardial infarction. The study was ap-
proved by the local ethics committee. Inferior myocardial
infarction was diagnosed by typical chest pain lasting
>30 min, ST segment elevation ?0.1 mV in two or more
leads of II, III and aVF and an increase in creatine kinase
(CK) above twice normal (> 140 Ulliters) <24 h after admis-
AV = atrioventricular : CK = creatine kinase
; ECU = electrocardiogram, Max = maximal ; VT = ventricular
tachycardia .
sion. Patients were included in the study when symptoms of
chest pain lasted <24 h before admission (mean [±SD] 6.1 ±
4.6 h, range 0 .5 to 23 h) . Clinical data of the patients are
presented in Table 1 .
Study protocol. In all patients a standard 12-lead electro-
cardiogram (ECO) (leads I to III, M, aVL, aVF, V, to V6 )
and right precordial ECG (leads V 3 to
V6R)
were recorded
immediately after admission to the hospital. ST segment
deviations were assessed 0.04 s after the J point in all 18
leads. Three consecutive QRS complexes were measured
using the PQ level as the isoelectric line . Only ST segment
elevations >0.I mV were evaluated. All prognostic analyses
wcte made by a cardiologist unaware of the clinical status of
the patient by using the ST segment elevation in lead VA
>0.1 mV as a marker of right ventricular infarction (29).
The diagnostic accuracy of ST segment elevation in lead
V4R indicating right ventricular infarction was determined
by 1) autopsy findings (27,33) ; 2) left/right ventriculography
and coronary angiography (the criterion was wall motion
abnormalities or occlusion or severe stenosis of the right
coronary artery >80% proximal to the right ventricular
branch [36]) ; 3) technetium-99m pyrophosphate imaging
(15 mCi of technetium-99m coupled with 5 mg of stannous
pyrophosphate ; the criterion was focal uptake of the right
ventricle [15,37]) ; and 4) invasive hemodynamic measure-
ments (the criterion was a right atrial pressure equal to the
pulmonary capillary pressure or a severe noncompliant
pattern [33,38]) .
Hemodynamic measurements and technetium-99m pyro-
phosphate imaging were considered only when performed
within the acute phase of myocardial infarction (<24 h) .
Sensitivity (percent of patients with right ventricular infarc-
tion correctly identified by ST segment elevation in lead
VA, specificity (percent of patients without right ventricu-
hWCVol. 2kNw2
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Table 1
. Clinical Characteristics and Hospital Outcome in 200 Consecutive Patients With Acute
Inferior Myocardial Infarction, With or Without Throtnbolytic Therapy
Patients With
Thrombolysis
Patients Without
Thrombolysis
(n = 129)(n=71)
Clinical characteristics
Gender (maleifemale) 58113 9584
Mean (±SD) age (yr) 61±7 67 ± 11
Previous myocardial infarction
8(11%) 25 (19915)
Max CK >1,000 Uditer
27 (38%) 34 (26%)
Shack an :dm ission 7(l0a) 15(12%)
ST segment elevation on ECU lead
V4R
a0.1 mV 41(58,7o) 66(51%)
Hospital outcome
Mortality 6(8%) 32 (25%)
Cardiolenic shock
8 (ii7a) 23(18%)
Ventricular fibrillation 9(13%) 22 (17%)
Sustained VT 10(149,0) 14 (l lib)
Complete AV block 7 j10%) 15 (12%)
Pacing requirement 7 (10%) 15 (12%)
Myocardial rupture, tamponade 4(S%) 5(7%)
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lar infarction without ST segment elevation in lead V
4R) and
diagnostic efficiency of ST segment elevation in lead V4R
(patients correctly identified by the presence or absence of
ST segment elevation in lead V4R) were calculated for each
of the four diagnostic tests . Thus, ST segment elevation in
lead VA
showed a high diagnostic efficiency for right
ventricular infarction compared with autopsy findings ([18
patients] sensitivity 88% [14 of 181, specificity 50% [1 of 2],
diagnostic accuracy 83% [IS of 18]);
coronary angiographyl
right ventriculography ([118 patients] sensitivity 89% 155
of
62], specificity 77% [43 of 56], diagnostic accuracy 83% [98
of 118)); technetium-99m pyrophosphate imaging ((92 pa-
tients] sensitivity 92% (48 of 52], specificity 80% [32 of 401,
diagnostic accuracy 87% [ of 92]); and hemodynamic
measurements ([68 patients] sensitivity 76% [28 of 37],
specificity 81% [25 of 31], diagnostic accuracy 78% [53 of
68]). Overall diagnostic accuracy was calculated by using
the results of the first test in each patient according to
the previous sequence (autopsy findings [18 patients],
angiographic/ventriculographic findings [112 patients),
technetium-99m pyrophosphate imaging [37 patients], hemp .
dynamic findings [20 patients]) . In 13 patients none of the
four tests could be adequately performed (e.g ., early death,
technical reasons), and they were excluded from this analy-
sis .
6olytic therapy. Thrombolytic therapy was used
in all eligible patients . Eligibility was defined before begin-
ning the study as follows : infarct symptoms lasting s6 h ;
age s75 years; patient consent; nocontraindications, includ-
ing poorly controlled hypertension (> 180 mm Hg systolic or
>110 mm Hg diastolic blood pressure) ; active bleeding ;
recent surgery or significant trauma; and any cerebrovascu-
lar accident or neoplasm (1,39) . Thrombolytic therapy was
performed using either intravenous streptokinase (1 .5 MIU
in I h), anisoylated plasminogen streptokinase (30 mg in
5 min) or recombinant tissue-type plasmi n activator
(100 mg in 3 h). Postthrombolytic therapy consisted of
heparin (500 to 1,000 Ulh intravenously), adjusted to keep
the partial thromboplastin time at 1.5 to 2 times the control
level for >24 h, and aspirin (100 mg/day) . Coronary balloon
` plasty was not performed routinely after thrombolytic
therapy .
evaluation. The in-hospital and long-term
course was determined in all patients. The prognostic impact
of ST segment elevation in lead V 4R was evaluated in
patients eligible or ineligible for thrombolysis with re rd to
mortality and the occurrence of major in-hospital complica-
tions, including ventricular fibrillation, sustained ventricular
tachycardia (>30 s or causing hemodynamic intolerance),
cardi nic shock (systolic blood pressure <90 mm Hg for
>30 min, together with signs of impaired peripheral circula-
tion or necessity of catecholamine administration), myocar-
dial rupture, third-degree AV block and asystole requiring
temporary or permanent cardiac pacing and reinfarction . All
complications were analyzed by whether they occurred
<24 h after admission or during the remaining in-hospital
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period. In patients with evidence of right ventricular infarc-
tion, volume loading was the therapy of choice ; nitres were
given only in the presence of pulmonary capillary wedge
pressure 2L, 15 ram Hg.
All patients were followed up for > 1 year . At the end of
follow-up, 141 patients were still alive . The observation
period ranged from 12 to 76 months (mean 37 ± 12 months) .
Information about vital status, including mode of death and
follow-up events (e.g ., reinfarction, cardiac pacing, aorto-
coronary artery bypass, coronary angioplasty), was obtained
from each patient or the general practitioner by means of a
standardized questionnaire .
Stalistical analysis. Mean values ± SD were calculated
for continuous variables and absolute and relative frequen-
cies for discrete variables (40) . Differences between groups
were examined for statistical significance by use of a two-
sample t test for continuous variables and the chi-square test
for discrete variables . The distribution of the patient survival
times, allowing for examination of long-term survival after
hospital discharge, was estimated using the Kaplan-Meier
method. The independent prognostic relevance of selected
clinical variables with respect to long-term survival was
assessed by applying the Cox proportional hazards multiple
regression model to patient survival times and included the
following clinical variables : gender, age, history of myo-
cardial infarction, time to treatment, cotnorbld disease,
CK >1, Ulliter on admission, cardiogenic shock on
admission and presence of ST segment elevation in lead V 4R
>0.1 mV on admission . The statistical significance of these
variables within the multivariate models was evaluated using
the Wald test (40). All tests of significance were two tailed
and used a significance level of p n; 0 .05 .
Results
ST segment elevation in lead V4R during the first ECG
on admission was observed in 107 patients (54%). When
compared with autopsy findings, leftfright angiography/
ventriculography, technetium-99m pyrophosphate imaging
and hemodynamic measurements, ST segment elevation
z0.1 mV in lead V4R had an overall sensitivity of 88%, a
specificity of 78% and a diagnostic efficiency of 83% for
demonstrating right ventricular infarction .
Prognostic Impact of right ventricular infarction d
acute Inferior myocardial infarction . During the in-hospital
period, 38 (19%) of 200 patients with acute inferior myocar-
dial infarction died, and 94 (47%) had major complications .
When acute inferior myocardial infarction was complicated
by right ventricular infarction, the in-hospital mortality rate
increased from 6% (6 of 93) to 31% (33 of 107) (p < 0 .0001),
and the complication rate increased from 28% (26 of 93) to
64% (68 of 107) (p < 0.0005) .
Thrombolytic therapy during acute inferior myocardial
infarction. Seventy-one patients (36%) with acute inferior
myocardial infarction were considered eligible for thrombo-
lytic therapy and underwent this form of treatment . The
JACC Vol. 24, No . 2
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Table 2. Multivariate Analysis of the Prognostic Impact of Clinical Variables Available in the Early Phase of Acute Inferior
Myocardial Infarction
0.59t
clinical data of patients with and without reperfusion therapy
are summarized in Table 1 .
Patients who underwent thrombolytic therapy had a
lower in-hospital mortality (8% [6 of 71]) and complication
(31% 122 of 71]) rate than those considered ineligible for
thrombolysis (25% [32 of 129], p < 0 .001 ; 56% [72 of 129],
respectively, p < 0.01) . In the two groups deaths (<24 h 13
patients; >24 h 25 patients) and major complications (<24 h
58 patients ; >24 h 36 patients) were highest during the 1st
24 h after admission. However, in multivariate analysis
when age, gender, peak CK, comorbid disease, time to
treatment, previous myocardial infarction and shock on
admission were considered, reperfusion therapy was of
independent prognostic importance only for in-hospital mor-
tality (Table 2) . Survival analysis for patients found eligible
or ineligible for reperfusion therapy is presented in Figure 1 .
Prognostic impact of right ventricular infarction in patients
eligible or ineligible for thrombolysis . Right ventricular in-
farction was present in 41 (58%) of 71 patients with and 66
(51%) of 129 patients without thrombolysis. In the pres-
ence of right ventricular infarction, patients undergoing
thrombolysis showed a 4 .2-fold lower mortality (10% vs
.
42%, p < 0.001) and 2.4-fold lower complication (34% vs .
54%, p < 0.05) rate than those considered ineligible for
thrombolysis . In the absence of right ventricular infarction
there was no difference in mortality (7% [2 of 30] vs . 6% [4
of 63], p = NS) and complication (27% IS of 30] vs. 29% [18
of 63], p = NS) rate regardless of whether the patient
underwent reperfusion therapy or not .
ST segment depression in the left precordial leads
(?0.1 mV in two or more leads V, to V 5) was observed in 87
(43%) of 200 patients
. In these patients the mortality rate was
higher (22% [19 of 87] vs. 11% 113 of 1131, p < 0
.05) when the
patient was considered ineligible for thrombolytic therapy .
In patients undergoing thrombolysis, no
difference in in-
hospital mortality rate was observed (3% [3 patients] vs . 3%
ZEHENDER ET AL
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0.60
*Relative risk (95% confidence interval) . tp value for column . Abbreviations as in Table I .
[3 patients], p = NS) . Adding patients with left precordial ST
segment depression and right precordial ST segment eleva-
tion did not have superior prognostic impact compared with
right precordial ST segment elevation alone .
When each major complication was analyzed separately,
patients with right ventricular infarction showed a lower
incidence of cardiogenic shock (p < 0.05), asystole (p <
0.05), third-degree AV block and pacing requirement when
reperfusion therapy was used . In patients without right
ventricular infarction there was an inverse but nonsignificant
trend for the majority of major complications (Fig . 2) .
Similar observations for the overall benefit of thrombolysis
were made when any of the criteria evidencing right ventric-
ular infarction during angiographic, scintigraphic or hemo-
dynamic measurements replaced ST segment elevation in
the right precordial leads .
Figure 1 . Kaplan-Meier analysis of cumulative survival rates for all
200 patients with acute inferior myocardial infarction during a
follow-up of I to 6 years (mean 3 .1 ± 1 years) . Survival rates are
stratified by the presence or absence of reperfusion therapy . Level
of significance describes the hospital and follow-up periods .
0
0.03t 0.20t
12 24 36 48 60 72 84
Months after myocardial infarction
ln-Hospital Phase
<24 h
=h
Variables Analyzed
Mortality
(p value)
Major
Complications Mortality
(p value) (p value)
Major
Complications
(p value)
Clinical criteria
Male gender
Age >70 yr
NS
NS
NS NS
NS * 103
NS
NS
Previous infarction
Max CK >1,000 lI/liter
Shock on admission
NS
?N S
< 0 .002
NS NS
NS NS
NS
NS
< 0 .003NS * OMI
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The prognostic impact of right ventricular infarction in
patients with and without reperfusion therapy verified by
multivariate analysis was visualized using Kaplan-Meier
analyses . In patients found eligible for thrombolytic therapy,
survival was very similar whether or not the patient had right
ventricular infarction (Fig . 3 [top]). However, when the
patient was ineligible for thrombolysis, the presence of right
ventricular infarction markedly determined the patient's
prognosis (Fig. 3 (bottom]) . In addition to eligibility for
thrombolysis, Kaplan-Meier graphics were influenced by
other clinical variables that were different in patients with
and without thrombolysis . After discharge from hospital,
the long-term prognosis was somewhat better in patients
who underwent thrombolytic therapy (2 [3%] of 65 pa-
tients with vs. 18 [19%] of 97 patients without thrombolysis
died, p < 0.01; 5 [8%) of 65 patients with vs . 9
[9%0l
of 97 patients without thrombolysis had a reinfarction, p
NS) independent of the presence or absence of right ventric-
ular infarction . This effect is mainly the result of the lower
mean age of the patients who underwent thrombolytic
therapy .
PBS
AV hif ret
Asyst P r hi 2. Mortality rate and prevalence of major
. AV
complications during the in-hospital phase of 200
consecutive patients with acute inferior myocar-
dial infarction with (top) or without (bottom) right
ventricular (RV) infarction involvement. Patients
are additionally stratified by the use of thrombo-
No RV Infarction lytic therapy (level of significance was calculated
by univariate analysis) . 11LAV block = third-
degree atrioventricular block ; VP = ventricular
fibrillation ; VT = ventricular tachycardia .
HS
0 No thra oly(v 63)
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Discussion
In a consecutive series of 200 patients with inferior
myocardial infarction, 36% were found eligible for thrombo-
lysis. Right ventricular infarction was reliably evidenced
from ST segment elevation in the right precordial leads and
was present in 57% of patients . In the presence of right
ventricular infarction, thrombolytic therapy was associated
with a lower in-hospital mortality (4 .2-fold, p < 0 .001) and
complication (1 .6-fold) rate (p < 0 .01). In patients without
right ventricular infarction, the in-hospital mortality and
complication rates were similar whether or not the patient
underwent thrombolysis .
oils of inferior myocardial infarction and use of
thrombolytic therapy. The use of thrombolytic therapy after
acute inferior myocardial infarction remains controversial .
Bates (41) recently reviewed the effect of thrombolysis on
left ventricular function and observed a beneficial effect of
reperfusion therapy . Other studies (42,43) demonstrated a
significant improvement in infarction zone function after
reperfusion therapy for inferior infarction . In a recent meta-
analysis by Grines and DeMaria (1) in 12,014 patients with
JACC Vol, 24, No. 2
August 1994:362-9
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Figure 3. Kaplan-Meier analysis of cumulative survival rates in
patients with (top) or without (bottom) thrombolysis during acute
inferior myocardial infarction with a follow-up of I to 6 years (mean
3 .1 ± 1 years) . Survival rates are stratified by the presence or
absence of right ventricular infarction . Level of significance de-
scribes the hospital and follow-up periods .
acute inferior infarction, thrombolysis reduced the 2-week to
1-year mortality rate from 8.7% to 6.8% (p < 0.0001) .
However, data were collected from nine studies, of which
six smaller studies failed to prove a significant benefit of
thrombolysis .
To improve the overall benefit of thrombolytic therapy in
inferior myocardial infarction, additional criteria have been
evaluated to identify subgroups of patients who would
benefit most from this form of therapy (6,44-48) . Right
ventricular infarction, present in 40% to 50% of patients with
inferior myocardial infarction, has been suggested most
recently to identify patients with an unfavorable course
(14-20). However, data on the benefit of thrombolytic ther-
apy in these patients are limited . In the TIM( [I trial,
thrombolytic therapy reduced the risk for right ventricular
dysfunction from 42% to 13% (23) . In two smaller studies
(24,25) improvement in right ventricular function as a result
of reperfusion therapy remained controversial .
Diagnostic assessment of right ventricular infarction during
acute inferior infarction . To guide thrombolytic therapy,
diagnostic assessment of right ventricular infarction must be
simple, reliable and widely and rapidly available after the
patient is admitted to the hospital . These criteria are best and
0
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only met when the right precordiai surface ECG is used to
diagnose right ventricular infarction (33) . In a recent review
by NOW et al . (29), ST segment elevation
;A I mV in the
right precordial lead V4R showed a diagnostic accuracy
>80 17o and thus was superior to all other ECG criteria . In the
present study, 54% of patients with inferior infarction
showed ST segment elevation in lead V411 on admission . In
comparison with invasive, scintigraphic and autopsy find-
ings, ST segment elevation in lead V411 had a sensitivity of
88% and a diagnostic accuracy of 83% for evidencing light
ventricular infarction. ST segment elevation in lead V 411
evidencing right ventricular infarction was also shown by
our (49) and other working groups (20,34,35) to be a strong
and independent prognostic variable .
Importance of right ventricular infarction for the Lenefit of
thrombolytic therapy . On the basis of previous recommen-
dations (1,39), 36% of patients with acute inferior infarction
were found eligible for reperfusion therapy . Patients under-
going thrombolysis showed a 3 .1-fold lower mortality and a
1 .8-fold lower complication rate during the in-hospital
course . This effect was considered to be a result of the
benefit of thrombolysis, as well as the better overall prog-
nosis of patients considered eligible for thrombolytic therapy
(i0) .
The prevalence of right ventricular infarction was similar
in patients considered eligible or ineligible for reperfusion
therapy . In patients with right ventricular infarction, the use.
of thrombolytic therapy was associated with a 4 .2-fold lower
in-hospital murtafity and a 2 .4-fold lower complication rate,
In particular, the incidence of cardiogenic shock and brady-
cardic rhythm disturbances was significantly lower in pa-
tients undergoing reperfusion therapy, whereas ventricular
tachyarrhythmias were similar in the two groups . Thus, in
patients undergoing thrombolysis, due to rapid reperfusion
to minimize myocardial damage, right ventricular infarction
diagnosed on admission lost its prognostic relevance for
immediate and long-term survival . In contrast, when the
patient was ineligible for thrombolysis, right ventricular
infarction was associated with a significant worsening of the
prognosis. The same observation was made when the pres-
ence of right ventricular infarction was demonstrated by
scintigraphic, hemodynamic or angiographic measurements .
Because multivariate analysis had shown that right ven-
tricular infarction was an independent prognostic value,
these data strongly argue for a superior beneficial effect on
prognosis in patients who present with right ventricular
infarction complicating acute inferior myocardial infarction
and are considered for thrombolysis . These data may also
question the overall benefit of thrombolysis in patients with
inferior infarction not complicated by right ventricular in-
farction and may help to settle the earlier controversy
surrounding the general benefit of thrombolytic therapy .
These data are also of interest for the 60% to 80% of patients
with contraindications for thrimbolysis who are known to
have a worse prognosis (1)
. W!yen relative contraindications
may limit the use of reperfusion therapy, right ventricular
368,
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infarction should be a strong argument for the use of
thrombolytic therapy or for the early use of direct percuta-
neous transluminal coronary angioplasty .
After discharge from hospital, the long-term course of
patients with and without right
ventricular-
infarction was
similar. Patients who underwent reperfusion therapy showed
better long-term survival in both groups because of the
benefit of thrombolysis as well as selection criteria (e.g ., age
<75 years) .
S y tats. Our analyses were not based on a
randomized study design . However, in a multivariate anal-
ysis of thrombolytic therapy none of the clinical variables
were found to independently reduce the prognostic impact of
right ventricular infarction . Therefore our data appear to
have clinical relevance, particularly because, at present,
data with respect to the prognostic impact of right ventricu-
lar infarction during thrombolytic therapy are very limited
or not available . In addition, on the basis of our present
knowledge of the benefit of thrombolytic therapy and clinical
outcome in patients with right ventricular infarction, it is no
longer possible to study patients with and without right
ventricular infarction randomized to receive either thrombo-
lytic therapy or placebo because of substantial ethical con-
siderations . Therefore, our data represent the largest group
of patients with right ventricular infarction studied for
prognostic reasons and may provide an important basis for
further studies addressing the importancet of right ventricular
infarction in thrombolytic therapy .
Cl hu . Involvement of the right ventricle
during acute inferior myocardial infarction is common, and
its early and reliable recognition by ST segment elevation in
lead V4R has important therapeutic implications . Thirty-six
percent of patients presenting with inferior myocardial in-
farction were considered eligible for reperfusion therapy. In
patients with right ventricular infarction complicating infe-
rior myocardial infarction, thrombolytic therapy was asso-
ciated with a significantly lower in-hospital mortality and
complication rate . Patients without right ventricular involve-
ment have a better prognosis overall after inferior myocar-
dial infarction that seems to be independent of whether
reperfusion therapy is used
. During clinical routine, the
presence of right ventricular infarction should be considered
as an additional argument for treating the patient with
thrombolytic therapy or direct coronary angioplasty, espe-
cially when only relative contraindications, such as border-
line age or time after onset of symptoms, are present .
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